Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 6Pancreatic Neoplasms 3Pancreatic Cyst 2Breast Neoplasms 2Wilms Tumor 1Uveal Melanoma 1Thyroid Nodule 1Thyroid Diseases 1Prostatic Neoplasms 1Peutz-Jeghers Syndrome 1Pancreatitis, Chronic 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Myasthenia Gravis 1Mesothelioma, Malignant 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Leukemia 1Intestinal Neuroendocrine Tumor 1Hyperthyroidism 1Hip Fractures 1Hematologic Neoplasms 1Goiter 1Glioma 1Glioblastoma 1Frailty 1Fractures, Spontaneous 1

Interventions

pembrolizumab 45Paclitaxel 42Carboplatin 34Bevacizumab 18Specimen Handling 17Letrozole 16lenvatinib 13Magnetic Resonance Spectroscopy 12dostarlimab 11Cisplatin 11Biopsy 11Taxes 10olaparib 9Fulvestrant 9Doxorubicin 9abemaciclib 8Megestrol Acetate 8Docetaxel 8durvalumab 7atezolizumab 7Nivolumab 7Gemcitabine 7Blood Specimen Collection 7palbociclib 6Oxaliplatin 6Observation 6Fluorouracil 6niraparib 5Surveys and Questionnaires 5Progestins 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Data Collection × 1 year × Clear all
NCT07220512 2025-10-24

The Better, Harder, Faster, Stronger Study

Wake Forest University Health Sciences

Recruiting
35 enrolled
Gynecologic

Frailty, Ovarian Neoplasms, Endometrial Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡